Revance Therapeutics (RVNC)
(Delayed Data from NSDQ)
$5.50 USD
+0.13 (2.42%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $5.49 -0.01 (-0.09%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth NA Momentum NA VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Revance Therapeutics (RVNC) reported earnings of -$0.36 per share, beating the Zacks Consensus Estimate of $-0.48 per share. This reflects a positive earnings surprise of 25.00%. Look out for RVNC's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 52.7%.
Earnings History
Price & Consensus
Zacks News for RVNC
Can Revance Therapeutics (RVNC) Climb 98.64% to Reach the Level Wall Street Analysts Expect?
RVNC: What are Zacks experts saying now?
Zacks Private Portfolio Services